GLP-1 Receptor Agonists and the Reduction of Alcohol-Related Hospitalizations in Alcohol Use Disorder
Episode Summary
New real-world evidence suggests semaglutide and tirzepatide may reduce alcohol-related hospitalizations among patients with AUD and metabolic disease, warranting further clinical trials.